BOSTON SCIENTIFIC CORPORATION Other Current Assets
BOSTON SCIENTIFIC CORPORATION (BSX) had Other Current Assets of $701.00 million as of 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2025-11-03
- 2025-09-30: Other Assets, Current $701.00M.
- 2025-06-30: Other Assets, Current $613.00M.
- 2025-03-31: Other Assets, Current $756.00M.
- 2024-12-31: Other Assets, Current $831.00M.
| Period end | Other Assets, Current |
|---|---|
| 2025-09-30 | $701.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $613.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $756.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $831.00M 10-Q · filed 2025-11-03 |
| 2024-09-30 | $674.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $756.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $671.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $621.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $741.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $773.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $711.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $731.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $884.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $874.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $889.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $799.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $792.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $777.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $855.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $751.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $894.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $925.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.04B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $880.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $921.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | $124.00M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $143.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $180.00M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $240.00M 10-Q · filed 2017-11-02 |
| 2015-12-31 | $254.00M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |